- $2.22bn
- $2.45bn
- $727.33m
U.S. RESEARCH ROUNDUP-Home Depot, Palo Alto Networks, Wendys
Neogenomics Inc expected to post a loss of 2 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Electronic Arts, Lyft, Uber Technologies
U.S. RESEARCH ROUNDUP- Booking Holdings, Expedia Group, Natera
U.S. RESEARCH ROUNDUP- Cerevel Therapeutics, Cytokinetics, Karuna Therapeutics
Brief: Corrected-Neogenomics Inc Sees 2023 Consolidated Revenue $585 Million- $592 Million (Not '$565 Million - $575 Million')
Neogenomics Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Appfolio, Iron Mountain, Neogenomics
Neogenomics Inc reports results for the quarter ended in June - Earnings Summary
Brief: NeoGenomics Q2 Gross Profit USD 59.9 Mln
Neogenomics Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Neogenomics Inc Says On June 26, Board Increased Size Of Board From Eight To Ten Members
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-Airbnb, Y-mAbs Therapeutics, Neuronetics
U.S. STOCKS ON THE MOVE-Boeing, TScan Therapeutic, Under Armour
U.S. STOCKS ON THE MOVE-Alto Ingredients, Squarespace, Palantir
U.S. STOCKS ON THE MOVE-ClearOne, Coty, Novavax
NeoGenomics gains after raising 2023 sales forecast
Neogenomics Inc reports results for the quarter ended in March - Earnings Summary